Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

1. Serum lipid levels are the risk factors of gallbladder stones: a population-based study in China.Lipids in health and disease · 2020
   Article
2. Response to: Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
   Article

Corrections and comments

• Commented on by
  Response to: Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis.
• Comment on
  Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis.

Authors and funding

3 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as